2025 Research Article Collection A specially curated list of peer-reviewed articles discussing the latest advancements in the diagnosis and treatment of patients living with Breast Cancer. Filter by TopicIntegrating Novel Therapeutics & Personal Care Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC) READ MORE Antibody-drug conjugates in breast cancer: current evidence and future directions READ MORE Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study READ MORE BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2– Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis READ MORE Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2– advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study) READ MORE Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer READ MORE Novel Strategies in Breast Cancer Management: from Treatment to Long-term Remission READ MORE Consultations of patients with cancer to enhance shared decision-making in Japan: A retrospective observational study READ MORE Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies READ MORE Different needs ask for different care: Breast cancer patients’ preferences regarding assessment of care needs and information provision in personalized aftercare READ MORE Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review READ MORE AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025 READ MORE Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study READ MORE A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer READ MORE Breast cancer: pathogenesis and treatments READ MORE Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis READ MORE Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial READ MORE Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer READ MORE Therapeutic strategies and landscape of metaplastic breast cancer READ MORE Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2– advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, −3, and −7 trials READ MORE A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study READ MORE Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes READ MORE Impact of combinatorial immunotherapies in breast cancer: a systematic review and meta-analysis READ MORE Precision oncology in patients with breast cancer: towards a ‘screen and characterize’ approach READ MORE Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial READ MORE Communication and support of patients and caregivers in chronic cancer care: ESMO Clinical Practice Guideline READ MORE Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer READ MORE Recent progress of CDK4/6 inhibitors’ current practice in breast cancer READ MORE Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer READ MORE Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives READ MORE Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up READ MORE 23P Consensus statements and expert recommendations for BRCAm breast cancer in the Asia-Pacific region (STREAM-AP) READ MORE Molecular tumour boards — current and future considerations for precision oncology READ MORE Development of a Breast Cancer Risk Prediction Model Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Korean Women READ MORE Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement READ MORE Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer READ MORE Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type READ MORE Targeting HER2-positive breast cancer: advances and future directions READ MORE Genomics to select treatment for patients with metastatic breast cancer READ MORE Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening READ MORE Barriers and facilitators to provide multidisciplinary care for breast cancer patients in five Latin American countries: A descriptive-interpretative qualitative study READ MORE How would you rate this content? Submit Rating
